Description
Description:
Diamicron MR 30 mg Tablet is a medication manufactured by Servier containing the active substance Gliclazide. It is formulated as a modified-release tablet, providing a controlled release of the medication over time.
Purpose and Indications:
Diamicron MR (Modified-Release) 30 mg Tablet is primarily used in the management of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus). It is indicated for the treatment of adult patients with type 2 diabetes mellitus when diet, physical exercise, and weight reduction alone are not sufficient to control blood glucose levels.
Mechanism of Action:
Gliclazide, the active ingredient in Diamicron MR, belongs to the class of medications known as sulfonylureas. It works by stimulating the release of insulin from the pancreas, which helps to lower blood glucose levels. Gliclazide primarily acts by binding to specific receptors on the pancreatic beta cells, leading to increased insulin secretion in response to glucose.
Administration:
Diamicron MR 30 mg Tablet is taken orally, usually once daily with breakfast or the first main meal of the day. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. The dosage may vary depending on individual patient factors such as blood glucose levels, response to treatment, and presence of other medical conditions.
Monitoring and Side Effects:
Patients taking Diamicron MR should be monitored for potential side effects and efficacy of treatment. Common side effects may include:
- Hypoglycemia (low blood sugar)
- Gastrointestinal disturbances such as nausea, vomiting, or diarrhea
- Skin reactions such as rash or itching
- Headache
- Dizziness
- Fatigue
It is important for patients to report any unusual or severe side effects to their healthcare provider.
Prescription Requirement:
Diamicron MR 30 mg Tablet is a prescription medication and should only be used under the guidance of a qualified healthcare professional. It is important to discuss with a doctor before starting gliclazide therapy, especially if there are underlying health conditions or concurrent medications.
Clinical Considerations:
Gliclazide therapy with Diamicron MR can help to improve glycemic control and reduce the risk of long-term complications associated with type 2 diabetes mellitus. However, it is important for patients to adhere to dietary and lifestyle modifications as prescribed by their healthcare provider to optimize treatment outcomes.
Patient Education:
Patients taking Diamicron MR should receive education about the purpose of the medication, proper administration techniques, potential side effects, and the importance of adherence to the prescribed treatment regimen. They should also be advised on strategies to manage hypoglycemia and recognize symptoms of low blood sugar.
Please note that the information provided here is for general informational purposes only and should not be considered as medical advice. Always consult with a healthcare professional for personalized guidance and treatment recommendations based on individual medical needs and conditions.
Reviews
There are no reviews yet.